Healthcare artificial intelligence survey data reveals a disconnect: whilst 94% of respondents anticipate productivity gains from generative AI, only 54% currently rate their GenAI capabilities as high-performing. This analysis of NTT DATA’s research across 425 GenAI decision-makers and influencers in 33 countries provides data on healthcare technology adoption patterns.

Healthcare organisations report increasing GenAI investment from 33% today to expected 59% within two years. Strategic alignment challenges persist, with only 40% of healthcare leadership confirming GenAI strategy strongly aligns with business objectives whilst 81% claim well-defined strategies. Infrastructure requirements, workforce preparedness gaps, and governance challenges present implementation complexities.

The survey findings show investment growth patterns and implementation challenges among healthcare adopters.

Research Context

NTT DATA’s executive insight report represents robust primary research conducted between September and October 2024, examining healthcare, life sciences, and pharmaceutical organisations globally. The methodology employed random sampling of GenAI decision-makers (94%) and influencers (6%), with 81% representing large enterprises exceeding 10,000 employees.

Research validation followed standard industry protocols with data presented at 95% confidence level and 5% margin of error. The geographic scope spanning 33 countries provides comprehensive international perspective on healthcare GenAI adoption patterns, making findings particularly valuable for competitive intelligence analysis and strategic market forecasting.

Strategic Deployment Patterns and Investment Trajectories

Healthcare organisations demonstrate clear deployment prioritisation across operational areas. Back-office and middle-office workflow automation leads implementation planning at 50%, alongside product development and R&D initiatives. Front-office employee activities and patient interactions follow at 49% and 40% respectively.

This deployment sequence reveals strategic risk management approaches among healthcare executives. Rather than implementing patient-facing GenAI applications immediately, organisations prioritise internal operational efficiency improvements where implementation risks remain more controllable.

Investment patterns show growth from current significant investment levels of 33% to expected 59% within 24 months. Strategic alignment challenges exist, with only 40% achieving strong business-strategy alignment whilst 81% claim well-defined GenAI strategies.

The operational focus on workflow automation and R&D indicates healthcare organisations view GenAI primarily as productivity enhancement rather than revolutionary care delivery transformation. This measured approach provides competitive advantages for organisations achieving successful implementation whilst creating market opportunities for providers offering governance, training, and integration services.

Infrastructure Modernisation and Data Readiness Challenges

Healthcare infrastructure limitations present substantial implementation barriers. An overwhelming 91% of executives report legacy infrastructure significantly affects GenAI utilisation capabilities, whilst only 43% establish optimal cloud infrastructure for GenAI scaling.

Data readiness challenges compound infrastructure limitations. Merely 48% of healthcare organisations have assessed data readiness foundations for scalable, secure GenAI implementation. Additionally, only 44% report sufficient investment in data storage and processing capabilities supporting GenAI workloads.

Cloud adoption shows 95% of healthcare organisations view cloud-based solutions as most practical for GenAI applications, whilst 43% report establishing optimal infrastructure. Survey data shows 91% report legacy infrastructure affects GenAI capabilities.

Data infrastructure includes governance, security, and compliance considerations. The survey shows 94% of organisations using GenAI for patient data collection and interpretation.

Workforce Development and Organisational Readiness

Healthcare workforce preparedness reveals significant capability gaps requiring strategic attention. Seventy-five percent of organisations report teams lack necessary GenAI skills, whilst only 38% possess adequate capabilities for GenAI integration into existing systems.

Training requirements extend beyond technical competencies to include change management and ethical considerations. Healthcare organisations recognise this challenge, with 93% actively addressing GenAI’s impact on employee roles and responsibilities. However, comprehensive approaches addressing both technical and cultural adaptation remain limited.

Skills development priorities focus on enabling clinicians and administrative staff to work more efficiently whilst maintaining patient-centred care approaches. Survey data shows 93% are addressing GenAI’s impact on employee roles and responsibilities.

The workforce development data shows 75% of organisations reporting skills gaps, whilst 93% address GenAI’s impact on employee roles and responsibilities. Healthcare organisations recognise training requirements need both technical competencies and change management.

Key Statistics and Insights

• 94% of survey respondents believe GenAI will boost productivity, yet only 54% rate current capabilities as high-performing
• Investment growth: 33% currently investing significantly, expected to reach 59% within two years
• Strategic alignment gap: 81% claim well-defined GenAI strategies, but only 40% achieve strong business alignment
• Infrastructure challenge: 91% report legacy systems significantly affect GenAI capabilities
• Data readiness limitation: Only 48% have assessed data foundations for scalable GenAI implementation
• Data investment gap: Less than 44% have invested sufficiently in data storage and processing capabilities
• Workforce skills gap: 75% report teams lack necessary GenAI competencies
• Security concerns: 83% consider GenAI technology security confidence very important, only 42% confident in current protections
• Cloud preference: 95% view cloud-based solutions as most practical for GenAI, yet only 43% establish optimal infrastructure
• ROI expectations: More than 80% consider proven ROI highly important, whilst 93% accept longer-term realisation
• Operational focus: Back-office automation (50%) and R&D (50%) lead deployment priorities over patient interactions (40%)

Technical Glossary

Generative AI (GenAI): Advanced artificial intelligence systems capable of creating new content, analyses, and insights from existing data, particularly valuable for healthcare applications including clinical decision support and operational automation.

Protected Health Information (PHI): Individually identifiable health information held or transmitted by covered entities or business associates, subject to HIPAA privacy and security requirements in healthcare GenAI implementations.

Legacy Infrastructure: Existing technology systems and platforms that may lack compatibility with modern GenAI applications, requiring modernisation or replacement for effective implementation.

Data Readiness: Organisational capability to provide clean, accessible, and compliant data necessary for effective GenAI model training and operation in healthcare environments.

Proof of Concept (POC): Small-scale implementation projects designed to demonstrate GenAI feasibility and value before full-scale deployment across healthcare operations.

Return on Investment (ROI): Financial metric measuring GenAI implementation benefits relative to costs, particularly important for healthcare organisations with complex budget constraints.

Workflow Automation: GenAI applications that streamline and optimise healthcare operational processes, reducing manual tasks and improving efficiency without direct patient interaction.

Strategic Alignment: Coordination between GenAI initiatives and broader organisational business objectives, essential for successful healthcare technology adoption.

Cloud Infrastructure: Remote computing resources and services that provide scalable platforms for GenAI implementation, preferred by healthcare organisations for flexibility and compliance capabilities.

Cybersecurity Framework: Comprehensive approach to protecting GenAI systems and healthcare data from unauthorised access, breaches, and other security threats.

Key Questions & Answers

How many healthcare organisations plan significant GenAI investment within two years?

59% of healthcare organisations expect to invest significantly in GenAI within the next two years, compared with current 33% levels.

How many healthcare executives report strategic alignment between GenAI and business objectives?

Only 40% of healthcare leadership agrees that GenAI strategy strongly aligns with business objectives, despite 81% claiming well-defined strategies.

What is the primary barrier to healthcare GenAI adoption?

Legacy infrastructure affects 91% of organisations’ ability to implement GenAI effectively, representing the most significant implementation barrier.

Which operational areas receive priority for GenAI deployment?

Back-office workflow automation and R&D both lead at 50%, followed by front-office employee activities (49%) and patient interactions (40%).

How prepared is the healthcare workforce for GenAI implementation?

75% of healthcare organisations report their teams lack necessary GenAI skills, indicating substantial training and development requirements.

What percentage of healthcare organisations prioritise cloud-based GenAI solutions?

95% view cloud-based solutions as most practical for GenAI applications, though only 43% have established optimal cloud infrastructure.

How important is ROI demonstration for healthcare GenAI investments?

More than 80% of executives consider proven ROI highly important, whilst 93% accept that ROI realisation will require longer-term perspectives.